{
  "nct_id": "NCT06875193",
  "title": "DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes",
  "status": "RECRUITING",
  "sponsor": "Dong Wha Pharmaceutical Co. Ltd.",
  "study_type": "INTERVENTIONAL",
  "phases": [
    "PHASE4"
  ],
  "enrollment_target": 196,
  "start_date": "2024-05-28",
  "primary_completion_date": "2025-12-31",
  "location_count": 1,
  "locations": [
    {
      "facility": "Kyung Hee University Hospital at Gangdong",
      "city": "Seoul",
      "state": null,
      "country": "South Korea",
      "status": "RECRUITING"
    }
  ],
  "contacts": "Study contacts are listed on the ClinicalTrials.gov record: https://clinicaltrials.gov/study/NCT06875193",
  "source": {
    "name": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06875193",
    "retrieved": "2026-11-16",
    "last_update_posted": "2025-03-17",
    "modified": "Fields selected and renamed by ChartStays; values unchanged."
  }
}
